WallStSmart

VivoPower PLC (VIVO)vsVuzix Corp Cmn Stk (VUZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Vuzix Corp Cmn Stk generates 9885% more annual revenue ($6.09M vs $61,000). VUZI leads profitability with a 0.0% profit margin vs 0.0%. VIVO earns a higher WallStSmart Score of 26/100 (F).

VIVO

Avoid

26

out of 100

Grade: F

Growth: 5.3Profit: 3.0Value: 5.0Quality: 4.0
Piotroski: 3/9

VUZI

Avoid

16

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for VIVO.

VUZIUndervalued (+40.5%)

Margin of Safety

+40.5%

Fair Value

$4.15

Current Price

$4.23

$0.08 discount

UndervaluedFair: $4.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

VIVO1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
47.6%10/10

Revenue surging 47.6% year-over-year

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Areas to Watch

VIVO4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$80.09M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

VUZI4 concerns · Avg: 3.5/10
Price/BookValuation
14.1x4/10

Trading at 14.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$259.45M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : VIVO

The strongest argument for VIVO centers on Revenue Growth. Revenue growth of 47.6% demonstrates continued momentum.

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bear Case : VIVO

The primary concerns for VIVO are EPS Growth, Market Cap, Return on Equity.

Bear Case : VUZI

The primary concerns for VUZI are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

VIVO profiles as a hypergrowth stock while VUZI is a value play — different risk/reward profiles.

VUZI carries more volatility with a beta of 1.69 — expect wider price swings.

VIVO is growing revenue faster at 47.6% — sustainability is the question.

VIVO generates stronger free cash flow (-3M), providing more financial flexibility.

Bottom Line

VIVO scores higher overall (26/100 vs 16/100) and 47.6% revenue growth. VUZI offers better value entry with a 40.5% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

VivoPower PLC

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Meridian Bioscience, Inc., a life sciences company, develops, manufactures, distributes and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases and elevated blood lead levels worldwide. The company is headquartered in Cincinnati, Ohio.

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Want to dig deeper into these stocks?